Vitamin D – The Cost To The NHS of Epidemic Deficiency And The
Overwhelming Case For Supplementation. From Cancer Research UK
The Government’s view Professor Mike Richards, National Cancer
Director, kicked off the session. He acknowledged that the UK
spends less on healthcare as a whole than many other European
countries. On top of this, we spend proportionally less on
cancer care than many of our EU counterparts. According to the
latest figures, around 5 per cent of the NHS spend is on cancer,
equating to around £76 per head each year in England …. Clearly
there is a need to increase spend in the NHS on cancer –
particularly when the demographics and new advances in cancer
drugs are taken into account. As the population ages, cancer is
getting more common – Professor Richards commented that the
incidence of the disease is increasing at a rate of around 1.5
per cent each year. This means there will inevitably be more
people needing cancer care services. And with great strides in
cancer research, many new drug